U.K. Biotech Stocks

AstraZeneca

Market Cap: UK£161.5b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£57.5b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Haleon

Market Cap: UK£36.8b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Hikma Pharmaceuticals

Market Cap: UK£4.6b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

HUTCHMED (China)

Market Cap: UK£1.7b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Genus

Market Cap: UK£1.4b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

Indivior

Market Cap: UK£1.1b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Oxford Biomedica

Market Cap: UK£325.9m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

PureTech Health

Market Cap: UK£310.8m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Faron Pharmaceuticals Oy

Market Cap: UK£275.4m

Operates as a clinical stage drug discovery and development company.

MaxCyte

Market Cap: UK£180.7m

A life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally.

Animalcare Group

Market Cap: UK£176.6m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Bioventix

Market Cap: UK£154.1m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

hVIVO

Market Cap: UK£119.1m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Avacta Group

Market Cap: UK£115.0m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

Diaceutics

Market Cap: UK£113.7m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

ECO Animal Health Group

Market Cap: UK£42.3m

Develops, registers, and markets pharmaceutical products for animals worldwide.

Futura Medical

Market Cap: UK£27.1m

Research, develops, and sells pharmaceutical and healthcare products for sexual health.

Tissue Regenix Group

Market Cap: UK£23.2m

A medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally.

Arecor Therapeutics

Market Cap: UK£16.2m

A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.

ProBiotix Health

Market Cap: UK£11.1m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

IXICO

Market Cap: UK£10.4m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

Aptamer Group

Market Cap: UK£7.2m

Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

Theracryf

Market Cap: UK£5.0m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioral brain disorders.

Verici Dx

Market Cap: UK£2.7m

Develops prognostic and diagnostic tests for kidney transplant patients.

Roquefort Therapeutics

Market Cap: UK£2.6m

A material biotech company, engages in the development of medicines for the treatment of cancer.

ValiRx

Market Cap: UK£2.1m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.